Search Results 1-10 of 21885 for Inhibition

  1. Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma - Mayo Clinic Research

    ... inhibition. Project aims. This project has three aims: Aim 1. Determine the dependence of CCA tumor progression on persistent YAP-TEAD signaling and ...

  2. Cortical Excitability and Inhibition in MDD - Clinical Trials

    Brain activity measures(known as cortical excitability and inhibition) will be collected by Transcranial Magnetic Stimulation (TMS). TMS is a noninvasive ...

  3. PCSK9 inhibition: A game changer in cholesterol management - Mayo Clinic

    PCSK9 inhibitors fill a therapeutic niche for patients with familial hypercholesterolemia or patients with statin intolerance who are not able to achieve ...

  4. Angiotensin-converting enzyme (ACE) inhibitors - Mayo Clinic

    ACE inhibitors are used to prevent, treat, or improve symptoms in conditions such as: High blood pressure, also called hypertension. Coronary artery disease.

  5. Project 1: Next-Generation TOP1 Inhibition To Treat Ovarian Cancer - Mayo Clinic Research

    Investigators in the Mayo Clinic Ovarian Cancer SPORE are assessing DNA topoisomerase 1 (TOP1) inhibitors to treat ovarian cancer.

  6. A Study Of Sclerostin Inhibition On T Cell Aging - Mayo Clinic

    The purpose of this study is to analyze T cells collected from patients before and after treatment with romosozumab to determine whether Wnt signaling is ...

  7. Heart Failure and Transplantation: Paul C. Tang - Mayo Clinic Research

    This image from our lab shows Nrf2 nuclear translocation in donor hearts after histone deacetylase inhibition. Purple and pink cultured cells depict ...

  8. ALPN-202 With PD-1 Inhibition in Advanced Malignancies - Mayo Clinic

    The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. Participation eligibility.

  9. Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure - Mayo Clinic

    Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure · Overview · Participation eligibility.

  10. CSF1R And TAM Receptor Inhibition With Q702 - Mayo Clinic

    The purpose of this study is establish the highest dose of Q702 tested that has acceptable tolerability and safety. Participation eligibility. Participant ...